ArticleJournal of immigrant and minority health2026
Elevated Blood Lead Levels Among Refugee Children in Urban Primary Care: A Retrospective Analysis Following Revised CDC Guidelines.
Article in Journal of immigrant and minority health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Refugee children are at increased risk for lead exposure due to environmental hazards encountered before, during, and after resettlement. In 2021, the Centers for Disease Control and Prevention (CDC) lowered the blood lead reference value (BLRV) from 5.0 to 3.5 micrograms per deciliter (µg/dL), prompting the need to reassess screening guidelines, practices, and follow-up care. This retrospective chart review evaluated blood lead levels (BLLs) among refugee and non-refugee children aged 1 to 6 years old who received care at an urban primary care center in Hartford, Connecticut (CT) from 2020 to 2023. Of 565 patients, 24 were identified as refugees. Refugee children had 1.94 times the risk of BLLs ≥ 3.5 µg/dL (p = 0.034) and 4.36 times the risk of BLLs ≥ 5.0 µg/dL (p = 0.0002) compared to non-refugees, while causing only a slight increase in prevalence. Refugees represented 4.2% of the total sample but 16.2% of children with BLLs ≥ 5.0 µg/dL. Notably, while refugees in this cohort originated from multiple countries, 83% of those with BLLs ≥ 5.0 µg/dL were born in or last resided in Afghanistan, suggesting that although there appears to be an association between this country and lead exposure, lead exposure risk may have occurred anywhere along the migration path, including the country of birth, the country of nationality, and intermediary countries where families lived prior to United States (U.S.) resettlement. These findings highlight the need to follow the CDC Refugee Health Guidelines for post-resettlement lead screening, and to work towards improved coordination between primary care providers and resettlement agencies. Although many refugee children may have experienced initial exposures overseas, public health efforts should not assume this eliminates new or ongoing exposure, as the family may have brought lead containing pottery or cosmetics with them, or are being resettled into an older home that may contain lead. So, there should be a focus on preventing further exposure, identifying sources of lead, and ensuring timely follow-up of elevated BLL. Broader policy and community engagement are essential to reduce disparities in lead exposure and the burden of elevated blood lead levels among refugee children.
Indexed as
Identifiers
42806177What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.